# EC_number_0162

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `EC_number`  
**Author expected answer:** **A** — 3.2.1.18

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MEPSKLFTMSDNATFAPGPVVNAADKKTFRTCFRILVLSVQAVTLILVIVTLGELVRMINDQGLSNQLSSIADKIRESATMIASAVGVMNQVIHGVTVSLPLQIEGNQNQLLSTLATIRTGKKQVSNCSTNIPLVNDLRFINGINKFIIEDYATHDFSIGHPLNMPSFIPTATSPNGCTRIPSFSLGKTHWCYTHNVINANCKDHTSSNQYISMGILVQTASGYPMFKTLKIQYLSDGLNRKSCSIATVPDGCAMYCYVSTQLETDDYAGSSPPTQKLTLLFYNDTVTERTISPTGLEGNWATLVPGVGSGIYFENKLIFPAYGGVLPNSTLGVKSAREFFRPVNPYNPCSGPQQDLDQRALRSYFPSYFSNRRVQSAFLVCAWNQILVTNCELVVPSNNQTLMGAEGRVLLINNRLLYYQRSTSWWPYELLYEISFTFTNSGQSSVNMSWIPIYSFTRPGSGNCSGENVCPTACVSGVYLDPWPLTPYSHQSGINRNFYFTGALLNSSTTRVNPTLYVSALNNLKVLAPYGNQGLFASYTTTTCFQDTGDASVYCVYIMELASNIVGEFQILPVLTRLTIT

[Multiple Choices]
A. 3.2.1.18
B. 3.2.1.8
C. 4.3.1.24
D. 1.1.1.122
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Commission (EC) Number Prediction, which is to predict the complete 4-digit Enzyme Commission (EC) number for a given protein. The EC number is a numerical classification that categorizes enzymes based on the chemical reactions they catalyze. You should select the most accurate EC number from the provided options based on the protein's sequence.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for mumps virus hemagglutinin-neuraminidase. That entry assigns EC 3.2.1.18 and cites evidence for hydrolysis of terminal sialic-acid linkages.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has features consistent with a viral membrane glycoprotein, but those features do not establish its catalytic activity or distinguish EC 3.2.1.18 from the alternatives.


**Missing item-specific fact**

> The protein-specific functional annotation or experimental evidence that this mumps viral protein acts as a neuraminidase (sialidase).


**Reason**

> The key is supported by reviewer-only, sequence-matched annotation, but the input supplies no functional context or decisive catalytic evidence. Selecting the precise EC requires an external protein-specific fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched annotation supports the keyed EC; the supplied evidence does not support another listed option.


### Important caveats

- The cited UniProt annotation is supported by a publication-linked evidence code; the primary study was not independently reviewed here.
- The reviewer-only accession and annotation were absent from the evaluated input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has features consistent with a viral membrane glycoprotein, but those features do not establish its catalytic activity or distinguish EC 3.2.1.18 from the alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional annotation or experimental evidence that this mumps viral protein acts as a neuraminidase (sialidase).",
    "reason": "The key is supported by reviewer-only, sequence-matched annotation, but the input supplies no functional context or decisive catalytic evidence. Selecting the precise EC requires an external protein-specific fact."
  },
  "case_id": "EC_number_0162",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for mumps virus hemagglutinin-neuraminidase. That entry assigns EC 3.2.1.18 and cites evidence for hydrolysis of terminal sialic-acid linkages."
  },
  "important_caveats": [
    "The cited UniProt annotation is supported by a publication-linked evidence code; the primary study was not independently reviewed here.",
    "The reviewer-only accession and annotation were absent from the evaluated input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched annotation supports the keyed EC; the supplied evidence does not support another listed option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "EC_number_0162",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for mumps virus hemagglutinin-neuraminidase. That entry assigns EC 3.2.1.18 and cites evidence for hydrolysis of terminal sialic-acid linkages.",
    "evidence_ids": ["C4", "C5", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has features consistent with a viral membrane glycoprotein, but those features do not establish its catalytic activity or distinguish EC 3.2.1.18 from the alternatives.",
    "missing_item_specific_fact": "The protein-specific functional annotation or experimental evidence that this mumps viral protein acts as a neuraminidase (sialidase).",
    "reason": "The key is supported by reviewer-only, sequence-matched annotation, but the input supplies no functional context or decisive catalytic evidence. Selecting the precise EC requires an external protein-specific fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched annotation supports the keyed EC; the supplied evidence does not support another listed option."
  },
  "important_caveats": [
    "The cited UniProt annotation is supported by a publication-linked evidence code; the primary study was not independently reviewed here.",
    "The reviewer-only accession and annotation were absent from the evaluated input."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry Q9WAF5 (Mumps orthorubulavirus Hemagglutinin-neuraminidase, HN_MUMPV) is annotated with EC 3.2.1.18, supported by experimental evidence (ECO:0000269, PubMed:39088577, Takahashi et al. 2024, Glycobiology). The catalytic activity is described as hydrolysis of alpha-(2→3)-, alpha-(2→6)-, alpha-(2→8)-glycosidic linkages of terminal sialic acid residues. Sequence match is exact (SHA256 confirmed, 582 AA). The annotation is present in both the current snapshot (v132) and the historical snapshot (v130).

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H2](#evidence-h2), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the well-known paramyxovirus neuraminidase catalytic motif 'KTHWCYTH' (residues ~175-182), which is a hallmark of the sialidase (neuraminidase) active site in the beta-propeller domain of paramyxovirus HN proteins. The overall domain architecture—N-terminal signal peptide, single transmembrane anchor, and large type-II ectodomain with a six-bladed beta-propeller fold—is characteristic of a viral surface glycoprotein with glycosidase activity. This narrows the EC class to hydrolases acting on glycosyl bonds (EC 3.2.1.x), eliminating the oxidoreductase (D: 1.1.1.122) and lyase (C: 4.3.1.24) options. The THW motif specifically indicates sialidase (neuraminidase) activity (EC 3.2.1.18) rather than endo-beta-N-acetylglucosaminidase activity (EC 3.2.1.8), which uses a distinct catalytic apparatus.


**Missing item-specific fact**

> None strictly required; however, recognizing the THW motif and the paramyxovirus HN domain architecture requires specialized virology knowledge that may not be universally available to all models.


**Reason**

> The THW catalytic motif and the viral surface glycoprotein architecture provide a concrete biological argument linking the sequence to sialidase activity. While this requires specialized virology knowledge, it constitutes general biological reasoning about protein motifs and domain architecture rather than memorization of a single database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options span three different EC top-level classes (oxidoreductase, lyase, hydrolase), and within the hydrolase class, the two glycosidase options (3.2.1.18 vs 3.2.1.8) are distinguishable by the presence of the THW neuraminidase motif. No two options are genuinely ambiguous given the sequence features.


### Important caveats

- The THW motif identification requires specialized virology knowledge; a model without training on paramyxovirus HN structure may not recognize this motif in a 582-residue sequence.
- The UniProt annotation for EC 3.2.1.18 is supported by experimental evidence (ECO:0000269) from a 2024 study, but the original benchmark may have been constructed from earlier annotations that relied on sequence similarity to other paramyxovirus HN proteins.
- The hemagglutinin (receptor-binding) activity of HN is not assigned a separate EC number, so the question correctly asks only for the neuraminidase EC number.
- Distinguishing 3.2.1.18 from 3.2.1.8 from sequence alone is non-trivial for a general-purpose model without virology-specific training.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the well-known paramyxovirus neuraminidase catalytic motif 'KTHWCYTH' (residues ~175-182), which is a hallmark of the sialidase (neuraminidase) active site in the beta-propeller domain of paramyxovirus HN proteins. The overall domain architecture—N-terminal signal peptide, single transmembrane anchor, and large type-II ectodomain with a six-bladed beta-propeller fold—is characteristic of a viral surface glycoprotein with glycosidase activity. This narrows the EC class to hydrolases acting on glycosyl bonds (EC 3.2.1.x), eliminating the oxidoreductase (D: 1.1.1.122) and lyase (C: 4.3.1.24) options. The THW motif specifically indicates sialidase (neuraminidase) activity (EC 3.2.1.18) rather than endo-beta-N-acetylglucosaminidase activity (EC 3.2.1.8), which uses a distinct catalytic apparatus.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; however, recognizing the THW motif and the paramyxovirus HN domain architecture requires specialized virology knowledge that may not be universally available to all models.",
    "reason": "The THW catalytic motif and the viral surface glycoprotein architecture provide a concrete biological argument linking the sequence to sialidase activity. While this requires specialized virology knowledge, it constitutes general biological reasoning about protein motifs and domain architecture rather than memorization of a single database entry."
  },
  "case_id": "EC_number_0162",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H2",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry Q9WAF5 (Mumps orthorubulavirus Hemagglutinin-neuraminidase, HN_MUMPV) is annotated with EC 3.2.1.18, supported by experimental evidence (ECO:0000269, PubMed:39088577, Takahashi et al. 2024, Glycobiology). The catalytic activity is described as hydrolysis of alpha-(2→3)-, alpha-(2→6)-, alpha-(2→8)-glycosidic linkages of terminal sialic acid residues. Sequence match is exact (SHA256 confirmed, 582 AA). The annotation is present in both the current snapshot (v132) and the historical snapshot (v130)."
  },
  "important_caveats": [
    "The THW motif identification requires specialized virology knowledge; a model without training on paramyxovirus HN structure may not recognize this motif in a 582-residue sequence.",
    "The UniProt annotation for EC 3.2.1.18 is supported by experimental evidence (ECO:0000269) from a 2024 study, but the original benchmark may have been constructed from earlier annotations that relied on sequence similarity to other paramyxovirus HN proteins.",
    "The hemagglutinin (receptor-binding) activity of HN is not assigned a separate EC number, so the question correctly asks only for the neuraminidase EC number.",
    "Distinguishing 3.2.1.18 from 3.2.1.8 from sequence alone is non-trivial for a general-purpose model without virology-specific training."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span three different EC top-level classes (oxidoreductase, lyase, hydrolase), and within the hydrolase class, the two glycosidase options (3.2.1.18 vs 3.2.1.8) are distinguishable by the presence of the THW neuraminidase motif. No two options are genuinely ambiguous given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "EC_number_0162",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry Q9WAF5 (Mumps orthorubulavirus Hemagglutinin-neuraminidase, HN_MUMPV) is annotated with EC 3.2.1.18, supported by experimental evidence (ECO:0000269, PubMed:39088577, Takahashi et al. 2024, Glycobiology). The catalytic activity is described as hydrolysis of alpha-(2→3)-, alpha-(2→6)-, alpha-(2→8)-glycosidic linkages of terminal sialic acid residues. Sequence match is exact (SHA256 confirmed, 582 AA). The annotation is present in both the current snapshot (v132) and the historical snapshot (v130).",
    "evidence_ids": ["C4", "C5", "C6", "H2", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the well-known paramyxovirus neuraminidase catalytic motif 'KTHWCYTH' (residues ~175-182), which is a hallmark of the sialidase (neuraminidase) active site in the beta-propeller domain of paramyxovirus HN proteins. The overall domain architecture—N-terminal signal peptide, single transmembrane anchor, and large type-II ectodomain with a six-bladed beta-propeller fold—is characteristic of a viral surface glycoprotein with glycosidase activity. This narrows the EC class to hydrolases acting on glycosyl bonds (EC 3.2.1.x), eliminating the oxidoreductase (D: 1.1.1.122) and lyase (C: 4.3.1.24) options. The THW motif specifically indicates sialidase (neuraminidase) activity (EC 3.2.1.18) rather than endo-beta-N-acetylglucosaminidase activity (EC 3.2.1.8), which uses a distinct catalytic apparatus.",
    "missing_item_specific_fact": "None strictly required; however, recognizing the THW motif and the paramyxovirus HN domain architecture requires specialized virology knowledge that may not be universally available to all models.",
    "reason": "The THW catalytic motif and the viral surface glycoprotein architecture provide a concrete biological argument linking the sequence to sialidase activity. While this requires specialized virology knowledge, it constitutes general biological reasoning about protein motifs and domain architecture rather than memorization of a single database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span three different EC top-level classes (oxidoreductase, lyase, hydrolase), and within the hydrolase class, the two glycosidase options (3.2.1.18 vs 3.2.1.8) are distinguishable by the presence of the THW neuraminidase motif. No two options are genuinely ambiguous given the sequence features."
  },
  "important_caveats": [
    "The THW motif identification requires specialized virology knowledge; a model without training on paramyxovirus HN structure may not recognize this motif in a 582-residue sequence.",
    "The UniProt annotation for EC 3.2.1.18 is supported by experimental evidence (ECO:0000269) from a 2024 study, but the original benchmark may have been constructed from earlier annotations that relied on sequence similarity to other paramyxovirus HN proteins.",
    "The hemagglutinin (receptor-binding) activity of HN is not assigned a separate EC number, so the question correctly asks only for the neuraminidase EC number.",
    "Distinguishing 3.2.1.18 from 3.2.1.8 from sequence alone is non-trivial for a general-purpose model without virology-specific training."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q9WAF5` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 130. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9WAF5.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:33:53.145631+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39088577","source":"PubMed"}],"value":"3.2.1.18"}],"fullName":{"value":"Hemagglutinin-neuraminidase"}}}
```

Source SHA-256: `f2c4b74d6065a62ee3de80fb119bec8f410076958143fbd7300617256d292508`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9WAF5.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:33:53.145631+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","reaction":{"ecNumber":"3.2.1.18","evidences":[{"evidenceCode":"ECO:0000269","id":"39088577","source":"PubMed"}],"name":"Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates."}}
```

Source SHA-256: `f2c4b74d6065a62ee3de80fb119bec8f410076958143fbd7300617256d292508`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q9WAF5.json)  
**Locator:** `/references/5`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:33:53.145631+00:00.  

```json
{"citation":{"authors":["Takahashi T.","Kurebayashi Y.","Otsubo T.","Ikeda K.","Konagaya K.","Suzuki S.","Yamazaki M.","Suzuki K.","Narimichi Y.","Minami A.","Takeuchi H."],"citationCrossReferences":[{"database":"PubMed","id":"39088577"},{"database":"DOI","id":"10.1093/glycob/cwae059"}],"citationType":"journal article","firstPage":"0","id":"39088577","journal":"Glycobiology","lastPage":"0","publicationDate":"2024","title":"Novel sialidase inhibitors suppress mumps virus replication and infection.","volume":"34"},"referenceComments":[{"type":"STRAIN","value":"13V165E2"}],"referenceNumber":6,"referencePositions":["CATALYTIC ACTIVITY"]}
```

Source SHA-256: `f2c4b74d6065a62ee3de80fb119bec8f410076958143fbd7300617256d292508`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9WAF5?format=txt&versions=130)  
**Locator:** `lines 6-7`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 130 / 1.  
**Retrieved:** 2026-11-02T04:33:57.899829+00:00.  

```text
DE   RecName: Full=Hemagglutinin-neuraminidase;
DE            EC=3.2.1.18 {ECO:0000269|PubMed:39088577};
```

Source SHA-256: `eadd08bd5c3ea900dbbb7f47921a7b42efcfc71e9582122d1a848e3de17765f7`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9WAF5?format=txt&versions=130)  
**Locator:** `lines 54-62`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 130 / 1.  
**Retrieved:** 2026-11-02T04:33:57.899829+00:00.  

```text
RN   [6]
RP   CATALYTIC ACTIVITY.
RC   STRAIN=13V165E2;
RX   PubMed=39088577; DOI=10.1093/glycob/cwae059;
RA   Takahashi T., Kurebayashi Y., Otsubo T., Ikeda K., Konagaya K., Suzuki S.,
RA   Yamazaki M., Suzuki K., Narimichi Y., Minami A., Takeuchi H.;
RT   "Novel sialidase inhibitors suppress mumps virus replication and
RT   infection.";
RL   Glycobiology 34:0-0(2024).
```

Source SHA-256: `eadd08bd5c3ea900dbbb7f47921a7b42efcfc71e9582122d1a848e3de17765f7`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q9WAF5?format=txt&versions=130)  
**Locator:** `lines 93-98`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 130 / 1.  
**Retrieved:** 2026-11-02T04:33:57.899829+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-
CC         (2->8)- glycosidic linkages of terminal sialic acid residues in
CC         oligosaccharides, glycoproteins, glycolipids, colominic acid and
CC         synthetic substrates.; EC=3.2.1.18;
CC         Evidence={ECO:0000269|PubMed:39088577};
```

Source SHA-256: `eadd08bd5c3ea900dbbb7f47921a7b42efcfc71e9582122d1a848e3de17765f7`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/EC_number.json), zero-based source row 162. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
